D.J. Back

Medicine · Health Sciences

32h-index2.9kcitations98works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(29), Pharmacogenetics and Drug Metabolism(28), Pharmacological Effects and Toxicity Studies(17), Reproductive Health and Contraception(16), Drug Transport and Resistance Mechanisms(15)

Publications97 total

Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravir
Journal of Antimicrobial Chemotherapy·2014· 7 citedOpen Access
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy
Journal of Antimicrobial Chemotherapy·2014· 36 citedOpen Access
Pharmacokinetics (PK) of the co-administration of raltegravir (RAL) and amlodipine (AML) to male and female healthy volunteers
2014
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
Journal of Antimicrobial Chemotherapy·2013· 12 citedOpen Access
Prediction of drug‐drug interactions between various antidepressants and ritonavir using a physiologically based pharmacokinetic model
Journal of the International AIDS Society·2012Open Access
Prevalence and type of drug‐drug interactions involving antiretrovirals in patients attending a specialist outpatient clinic in Kampala, Uganda
Journal of the International AIDS Society·2012· 2 citedOpen Access
Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV‐infected subjects
Journal of the International AIDS Society·2012· 1 citedOpen Access
Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV‐infected patients: evaluation of lower ritonavir dose
Journal of the International AIDS Society·2012· 4 citedOpen Access
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
Journal of Antimicrobial Chemotherapy·2012· 87 citedOpen Access
CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study
Journal of Antimicrobial Chemotherapy·2011· 32 cited
Ageing with HIV: medication use and risk for potential drug-drug interactions
Journal of Antimicrobial Chemotherapy·2011· 158 citedOpen Access
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers
Journal of Antimicrobial Chemotherapy·2011· 5 cited
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin
Journal of Antimicrobial Chemotherapy·2010· 23 citedOpen Access
Population pharmacokinetics of unboosted atazanavir and influence of the pregnane -x- receptor PXR 63396C > T
2010
Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets
Journal of Antimicrobial Chemotherapy·2009· 31 citedOpen Access
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
Journal of Antimicrobial Chemotherapy·2009· 38 citedOpen Access
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
Journal of Antimicrobial Chemotherapy·2009· 30 citedOpen Access
Combined effect of SLCO1B1 521T>C, PXR 63396C>T, and ABCB1 3435C>T on the achievement of therapeutic concentrations of unboosted Atazanavir
2009· 3 cited
A rapid and sensitive HPLC–MS method for the detection of plasma and cellular rifampicin
Journal of Chromatography B·2007· 40 cited
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals
Clinical Pharmacology & Therapeutics·2005· 73 cited
page 1 of 5Next →

Frequent Co-authors

AM Breckenridge(11), P.H. Rowe(8), J. Tjia(8), M.L'E. Orme(8), Michael Orme(7), Saye Khoo(5), Francesca E. Crawford(5), M Bruce MacIver(4), B.K. Park(4), S.F.M. Grimmer(4), Patrick G. Hoggard(3), James L. Maggs(3), Michael Barry(3), Máirín Ryan(3), SH Khoo(3), Stephen A. Ward(3), Rachel Weber(2), Hansjakob Furrer(2), Matthias Cavassini(2), Alexandra Calmy(2)